{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:59:36Z","timestamp":1794293976910,"version":"4.9.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191592","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T18:41:31Z","timestamp":1516905691000},"page":"e0191592","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":99,"title":["Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-1269","authenticated-orcid":true,"given":"Jean-Pierre","family":"Bassand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Accetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Al Mahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Corbalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A. A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G. G.","family":"Turpie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"van Eickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek W. A.","family":"Verheugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the GARFIELD-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"CT January","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"ref2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"38","key":"ref3","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF","volume":"37","author":"JP Bassand","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"Np1","DOI":"10.1177\/2047487316653709","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR)","volume":"23","author":"MF Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"27","key":"ref5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"P Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"PE Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"AK Kakkar","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"AK Kakkar","year":"2012","journal-title":"Am Heart J"},{"key":"ref9","first-page":"114","article-title":"Evolving quality standards for large-scale registries: the GARFIELD-AF experience","volume":"3","author":"KAA Fox","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"S van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"ref11","first-page":"85","article-title":"A multivariate technique for multiply imputing missing values using a sequence of regression models","volume":"85","author":"TE Raghunathan","year":"2001","journal-title":"Survey Methodology"},{"issue":"14","key":"ref12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995\u20132008: a Swedish nationwide long-term case-control study","volume":"34","author":"T Andersson","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/europace\/euv390","article-title":"&apos;Real-world&apos; management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry","volume":"18","author":"G Boriani","year":"2016","journal-title":"Europace"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"e000290","DOI":"10.1136\/openhrt-2015-000290","article-title":"Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study","volume":"2","author":"L Fauchier","year":"2015","journal-title":"Open Heart"},{"issue":"6","key":"ref15","first-page":"929","article-title":"Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization","volume":"19","author":"D Massera","year":"2017","journal-title":"Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"SD Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"TJ Wang","year":"2003","journal-title":"Circulation"},{"issue":"25","key":"ref18","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"A Alonso","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","article-title":"Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"167","author":"EC O'Brien","year":"2014","journal-title":"Am Heart J"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"JB Olesen","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"CE Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"L Friberg","year":"2010","journal-title":"Eur Heart J"},{"issue":"1","key":"ref23","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"MS Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/ehn101","article-title":"Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?","volume":"29","author":"R Nieuwlaat","year":"2008","journal-title":"Eur Heart J"},{"issue":"15","key":"ref25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"ref26","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"A Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"ref27","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/heartjnl-2016-309741","article-title":"Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom","volume":"102","author":"K Senoo","year":"2016","journal-title":"Heart"},{"issue":"15","key":"ref28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/heartjnl-2013-303767","article-title":"Ethnicity and stroke risk in patients with atrial fibrillation","volume":"99","author":"R Mathur","year":"2013","journal-title":"Heart"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1253\/circj.CJ-10-1119","article-title":"Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry","volume":"75","author":"H Atarashi","year":"2011","journal-title":"Circ J"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2012.08.012","article-title":"Thromboembolism in patients with nonvalvular atrial fibrillation: comparison between Asian and Western countries","volume":"61","author":"H Inoue","year":"2013","journal-title":"J Cardiol"},{"issue":"20","key":"ref31","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Z Hijazi","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"M Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"e1002169","DOI":"10.1371\/journal.pmed.1002169","article-title":"Under-prescribing of prevention drugs and primary prevention of stroke and transient ischaemic attack in UK general practice: a retrospective analysis","volume":"13","author":"GM Turner","year":"2016","journal-title":"PLoS Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S76651","article-title":"Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease","volume":"11","author":"DC Chen","year":"2015","journal-title":"Vasc Health Risk Manag"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/STROKEAHA.112.652305","article-title":"Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines\u2014Stroke 2003\u20132010","volume":"43","author":"NB Allen","year":"2012","journal-title":"Stroke"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/hrt.2005.079673","article-title":"Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry","volume":"92","author":"M Heras","year":"2006","journal-title":"Heart"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/2048872615610893","article-title":"Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry","volume":"6","author":"E Puymirat","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2369-14-230","article-title":"Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers","volume":"14","author":"MM Estrella","year":"2013","journal-title":"BMC Nephrol"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-007-0016-3","article-title":"Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review","volume":"12","author":"MD Philipneri","year":"2008","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/JAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF","volume":"1","author":"GC Fonarow","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.114.013451","article-title":"Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome","volume":"131","author":"RH Mehta","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"EJ Armstrong","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCULATIONAHA.106.669101","article-title":"Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes","volume":"116","author":"GH Gislason","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ahj.2014.09.015","article-title":"Translation of acute coronary syndrome therapies: from evidence to routine clinical practice","volume":"169","author":"M Putera","year":"2015","journal-title":"Am Heart J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:29:47Z","timestamp":1589840987000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191592"}},"subtitle":[],"editor":[{"given":"Marc W.","family":"Merx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191592","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.t006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0191592.s002","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]}}}